GlassScriptPhysician profile
Mark W Elliott
NPI 1053349415
$3,286.09
in general payments reported to CMS, 2019-2025
10 companies · $461 in 2025
The $461 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $89.40 · 2021: $690 · 2022: $1,263 · 2023: $423 · 2024: $208 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,244.79 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $233.02 | 2019-2025 | Axs Vecta 71, Axs Catalyst 7, Clottriever Bold Catheter |
| Rapid Medical LTD | $168.22 | 2025 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Penumbra, INC. | $148.66 | 2021-2023 | Indigo System |
| Imperative Care, INC | $128.64 | 2025 | Zoom 88-T Large Distal Platform |
| Boston Scientific Corporation | $97.24 | 2022 | |
| Medtronic USA, INC. | $89.40 | 2020 | |
| Medtronic, INC. | $70.85 | 2021-2025 | Solitaire X |
| Ekos Corporation | $56.18 | 2019 | |
| Terumo Medical Corporation | $49.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Elliott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.